BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


October Archive 2004 - have your press release here?

RNAi therapeutics company atugen receives Frost & Sullivan Award

POTENT PRECLINICAL EFFECT OF NOVEL MELANOMA PEPTIDE VACCINE REPORTED AT THE SEVENTH INTERNATIONAL ANTICANCER CONFERENCE IN CORFU, GREECE

Generex Biotechnology introduces Glucose Spray; First Product of the Diabetes Management System to reach the market

Nonlinear Dynamics and GenoLogics Life Sciences Software announce partnership for integrated protein informatics solution

SYMPHOGEN ANNOUNCES USD 25 MILLION FINANCING FROM INTERNATIONAL INVESTORS

DR. DAVID OSBORNE, VP PRODUCT DEVELOPMENT AT DOW PHARMACEUTICAL SCIENCES, SPEAKS AT SOCIETY FOR INVESTIGATIVE DERMATOLOGY COURSE IN PHILADELPHIA 

Agilent Technologies Completes Acquisition of Silicon Genetics, Leading Provider of Life Science Informatics

BIO Deutschland: Independent Biotechnology Industry Organisation Founded

Tipranavir submission takes fight to HIV mutations

Proteom and 14TM announce a strategic partnership in GPCR ligand design

OXFORD BIOMEDICA AND ARIUS RESEARCH EXTEND COLLABORATION ON NOVEL CANCER TARGETS

Sentrx Announces Reseller Agreement with Zenosis Limited Coincides with the Release of Zenosis Pharmacovigilance Modules

MorphoSys Reports third quarter 2004 results. Company expects to obtain profitablity by 2005

Internationals Flock to see Best of Australian Biotech

Ashlee Simpson - Too Young for Acid Reflux? - No - millions of children and teens have it

Nonlinear Dynamics Appoints Elchrom Scientific as TotalLab Distributor

First Annual RNAi Europe Conference and Exhibition - A Major Success

DRI launches high sensitivity RNA purification products based on ChargeSwitch technology

siFECTamineT is superior to in vitro market leader says new Biochemistry paper

BioPortfolio Bulletin - CNS Disorders markets, news, links and reports

Cardiovascular risks of HRT confirmed

ADHD children not coming to attention of Drs 

Petra Biotek Announce the Availability of Technology Designed to Optimize Dose Modification, Accelerate Drug Development and to Limit Failure of Phase I and II Clinical Trials

An introduction to the key CNS Disorders

BioPartners Submits an Application for Approval of the First Biosimilar Recombinant Interferon alpha for Hepatitis C in Europe

Visions of Biotechnology - a Community Forum into 2020

Best of Biotechnology on Show in Brisbane

The CNS Market Outlook to 2009

The Cancer Market Outlook to 2009

The Cardiovascular Market Outlook to 2009

PARI Aerosol Research Institute’s Formulation Work and eFlow Featured in Corus Pharma’s Positive Phase II Trial Results

Nonlinear Dynamics announce listings in Deloitte Fast 50 and Sunday Times Tech Track 100

ASINEX LTD. AND RECORDATI S.P.A. ANNOUNCE AN INTEGRATED DRUG DISCOVERY PROJECT

ASINEX and SIENABIOTECH announce Lead Generation Collaboration

COX-2 withdrawal - Therapeutic, R&D and pharmaceutical impact report

Flu season begins but a vaccine shortage awaits

Nonlinear Dynamics announces another year of record figures

Liponex announces U.S. patent and trial results for drug that boosts good cholesterol

GM crop opponents’ theory on co-existence “exaggerated” 

New Automated Colony Counter Used to Detect a Range of Diverse Bacteria at Major Food Testing Centre

Agilent Technologies' New Spin Cartridges Remove High-Abundance Proteins from Blood Serum Using Benchtop Centrifuge

Human Genome Pioneer Joins AusBiotech 2004 - Unravelling the Genetic Code of Australia’s Biodiversity

Umicore to manufacture product for Oxonica's photostable OPTISOLT UV Absorber

TxCell raises EUR10.5 million Series A to finance phase I-IIA clinical trials

Sigma Partners with Ingex on Targeted Gene Disruption Technology

Sirenade announces breakthrough in the development of Tau-Directed theraputics for Alzheimer's

PowderMed initiates a phase I clinical trial for a therapeutic Herpes Simplex type 2 vaccine

GENEREX BIOTECHNOLOGY PRESENTS INFORMATION AT THE EUROCONFERENCE VACCINES 3 MEETING OF THE PASTEUR INSTITUTE IN PARIS ON THE USE OF NOVEL PEPTIDE VACCINE FOR MELANOMA

GENOME express launches Gextrack, for food identification through DNA analysis

Cambridge Healthtech Institute - Licensing and Partnering Congress

Emma Palmer appointed as Associate Director, head of Financial PR/IR

Life after Vioxx - $2.5 billion up for grabs?

HIV infection - changes in epidemiology driving R&D development and increased market value

Dr. Eric von Hofe appointed Generex VP for Product Development & Scientific Affairs

Icoria, Inc. Expands Partnership with Agilent Technologies to Include $11.7 Million ATP Grant for Informatics

Entomed appoints Dr. Yves Ribeill to its board of directors

Agilent Technologies Donates Microarrays to Vanderbilt University for Courses in Genomic Technologies, Bioinformatics

Therapeutic activity of Bayer's BAY 43-9006 in renal cell carcinoma

Osteoarthritis treatment and markets post VIOXX - reports, news, opinions

Validated blood tests provide new alternative to liver biopsy for assessing status of liver disease in hepatitis C patients

Agilent Technologies Announces More Than One Million Bioanalyzer Chips Sold

Generex Biotechnology Corporation Oral-lyn™, the Company’s proprietary oral insulin spray formulation, and its RapidMist™ Diabetes

Sigma-Aldrich and Rubicon Genomics announce GenomePlexT Whole Genome Amplification Licensing Agreement

Atlas Venture and Global Life Science Ventures invest in Nitec Pharma AG

Asthma Control and Asthma Impact Surveys Launched by QualityMetric

NextGen Sciences Ltd introduces a new suite of revolutionary tools for molecular biology and protein research

Cobra Biomanufacturing appoints Cathy Smith to strengthen North America Sales

New molecular target identified for the prevention of Alzheimer's disease

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.